MLNT News and Press, Melinta Therapeutics Inc - Ordinary Shares From 08/09/19

MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced changes to its board of directors and execut...

~ Revenue of $16.0 million, Including Net Product Sales of $13.8 million, for the Second Quarter 2019 ~ ~ Reduction of Operating Expenses of 32 Percent, or $16.3 million, Year-Over-Year ~ ~ Commenced Enrollment in Clinical Trial Evaluating Orbactiv ® (oritavancin) Shorte...

~ Second Quarter 2019 Financial Results to be Reported on Friday, August 9, 2019 ~ ~ Company Cancels Previously Scheduled Earnings Call ~ MORRISTOWN, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the develo...

Gainers: ABMD   +5.7% . OBLN   +5.6% . ACOR   +5.1% . ERIC   +4.2% . More news on: Abiomed, Inc., Obalon Therapeutics, Inc., Acorda Therapeutics, Inc., Stocks on the move, , News on ETFs Read more ...

Immuron (NASDAQ: IMRN ) +134%  on revenue surge . More news on: Immuron Limited, Neovasc Inc., Bio-Path Holdings, Inc., Stocks on the move, Read more ...

Melinta Therapeutics (NASDAQ: MLNT ) has reported preliminary Q2 results and provided a corporate update. More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

~ Expects to Report Second Quarter 2019 Net Product Sales of Approximately $13.8 Million, Which Represents an Increase of 17 Percent Over the First Quarter of 2019 ~ ~ Anticipates Having Approximately $90 Million of Cash and Cash Equivalents on Hand at the End of the Second Qua...

Gainers: HELE   +7.4% . WDFC   +3.5% . OCX   +1.5% . MLNT   +1.4% . AUO   +1.4% . More news on: Helen of Troy Limited, WD-40 Company, OncoCyte Corporation, Stocks on the move, Read more ...

Gainers:  OMNOVA Solutions (NYSE: OMN ) +55% . SELLAS Life Sciences Group (NASDAQ: SLS ) +46% . Karyopharm Therapeutics (NASDAQ: KPTI ) +36% . One Stop Systems (NASDAQ: OSS ) +26% . NIO (NYSE: NIO ) +15% . Corvus Pharmaceuticals (NASDAQ: CRVS ) +15% . Melinta Therapeutics (NASDA...

Citing a "lack of clarity" regarding its ability to meet certain requirements under its loan with Vatera Investment Partners LLC, Melinta Therapeutics (NASDAQ: MLNT ) discloses that it will unable to draw additional funds under the $135M loan. More news on: Melinta Therapeutics, Inc., He...